Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | GFH009 |
Synonyms | |
Therapy Description |
GFH-009 inhibits CDK9, resulting in decreased activation of RNA Pol II and transcription of anti-apoptotic proteins, potentially leading to increased apoptosis and decreased proliferation of tumor cells (NCI Thesaurus). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
GFH009 | GFH-009|GFH 009 | CDK9 Inhibitor 21 | GFH-009 inhibits CDK9, resulting in decreased activation of RNA Pol II and transcription of anti-apoptotic proteins, potentially leading to increased apoptosis and decreased proliferation of tumor cells (NCI Thesaurus). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|---|---|---|---|---|---|
NCT04588922 | Phase I | GFH009 | A Study of GFH009 in Patients With Hematologic Malignancies | Recruiting | USA | 1 |